These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28727072)

  • 1. The equine glucose-dependent insulinotropic polypeptide receptor: A potential therapeutic target for insulin dysregulation.
    Kheder MH; Sillence MN; Bryant LM; de Laat MA
    J Anim Sci; 2017 Jun; 95(6):2509-2516. PubMed ID: 28727072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
    Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
    Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
    Irwin N; McClean PL; O'Harte FP; Gault VA; Harriott P; Flatt PR
    Diabetologia; 2007 Jul; 50(7):1532-40. PubMed ID: 17486314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors.
    Younan SM; Rashed LA
    Gen Physiol Biophys; 2007 Sep; 26(3):181-93. PubMed ID: 18063845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of short-term chemical ablation of the GIP receptor on insulin secretion, islet morphology and glucose homeostasis in mice.
    Irwin N; Gault VA; Green BD; Greer B; McCluskey JT; Harriott P; O'Harte FP; Flatt PR
    Biol Chem; 2004 Sep; 385(9):845-52. PubMed ID: 15493880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat.
    Chan CB; Pederson RA; Buchan AM; Tubesing KB; Brown JC
    Diabetes; 1984 Jun; 33(6):536-42. PubMed ID: 6373459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
    Tseng CC; Kieffer TJ; Jarboe LA; Usdin TB; Wolfe MM
    J Clin Invest; 1996 Dec; 98(11):2440-5. PubMed ID: 8958204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes.
    Gault VA; Irwin N; Green BD; McCluskey JT; Greer B; Bailey CJ; Harriott P; O'harte FP; Flatt PR
    Diabetes; 2005 Aug; 54(8):2436-46. PubMed ID: 16046312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16).
    Irwin N; Green BD; Parker JC; Gault VA; O'Harte FP; Flatt PR
    Regul Pept; 2006 Jul; 135(1-2):45-53. PubMed ID: 16675042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in
    Shimazu-Kuwahara S; Harada N; Yamane S; Joo E; Sankoda A; Kieffer TJ; Inagaki N
    Mol Metab; 2017 Mar; 6(3):288-294. PubMed ID: 28271035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GIP biology and fat metabolism.
    Yip RG; Wolfe MM
    Life Sci; 2000; 66(2):91-103. PubMed ID: 10666005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide.
    Gault VA; Harriott P; Flatt PR; O'Harte FP
    Biosci Rep; 2002; 22(5-6):523-8. PubMed ID: 12635849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-dependent insulinotropic polypeptide as a regulator of beta cell function and fate.
    Wideman RD; Kieffer TJ
    Horm Metab Res; 2004; 36(11-12):782-6. PubMed ID: 15655709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes.
    Gault VA; Hunter K; Irwin N; Greer B; Green BD; Harriott P; O'Harte FP; Flatt PR
    Biol Chem; 2007 Feb; 388(2):173-9. PubMed ID: 17261080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational, receptor interaction and alanine scan studies of glucose-dependent insulinotropic polypeptide.
    Venneti KC; Malthouse JP; O'Harte FP; Hewage CM
    Biochim Biophys Acta; 2011 Jul; 1814(7):882-8. PubMed ID: 21539943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
    McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1746-55. PubMed ID: 17848629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor.
    Gremlich S; Porret A; Hani EH; Cherif D; Vionnet N; Froguel P; Thorens B
    Diabetes; 1995 Oct; 44(10):1202-8. PubMed ID: 7556958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-dependent Insulinotropic Polypeptide (GIP): From prohormone to actions in endocrine pancreas and adipose tissue.
    Ugleholdt R
    Dan Med Bull; 2011 Dec; 58(12):B4368. PubMed ID: 22142579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of gastric inhibitory polypeptide in postprandial hyperinsulinemia of obesity.
    Roust LR; Stesin M; Go VL; O'Brien PC; Rizza RA; Service FJ
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E767-74. PubMed ID: 3287953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central GIP signaling stimulates peripheral GIP release and promotes insulin and pancreatic polypeptide secretion in nonhuman primates.
    Higgins PB; Shade RE; Rodríguez-Sánchez IP; Garcia-Forey M; Tejero ME; Voruganti VS; Cole SA; Comuzzie AG; Folli F
    Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E661-E670. PubMed ID: 27530231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.